Guidelines of care for the management of primary cutaneous melanoma
Susan M. Swetter(Stanford University), Toyin Lamina(American Academy of Dermatology), Clara Curiel‐Lewandrowski(University of Arizona), Hensin Tsao(Boston University), John A. Thompson(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Christopher K. Bichakjian(University of Michigan), Oliver J. Wisco(Brown University), Shasa Hu(University of Miami), Jane M. Grant‐Kels(University of Connecticut), Jeffrey E. Gershenwald(The University of Texas MD Anderson Cancer Center), David E. Elder(Hospital of the University of Pennsylvania), Timothy M. Johnson(University of Michigan), Arthur J. Sober(Johns Hopkins University), Valerie Guild(AIM at Melanoma Foundation), Samantha Wyatt, Allan C. Halpern(Memorial Sloan Kettering Cancer Center)
Cited by 707
Related Papers
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma
|New England Journal of Medicine|2017|1.4k
Skin Lesion Analysis Toward Melanoma Detection 2018: A Challenge Hosted by the International Skin Imaging Collaboration (ISIC)
|arXiv (Cornell University)|2019|990
Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis
|The Lancet Oncology|2018|658
Management of Immunotherapy-Related Toxicities, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2019|560